M J Rybak|S C Boike - JoVE Visualize

Showing results (81-90 of 131) with videos related to

Pageof 14

Sort By:

Clinical Pharmacokinetics|September 1, 1988

Inhibition of drug metabolism by quinolone antibioticsD J Edwards, S K Bowles, C K Svensson, et al.

Antimicrobial Agents and Chemotherapy|May 1, 1992

Pharmacokinetics and bactericidal rates of daptomycin and vancomycin in intravenous drug abusers being treated for gram-positive endocarditis and bacteremiaM J Rybak, E M Bailey, K C Lamp, et al.

Antimicrobial Agents and Chemotherapy|December 1, 1992

Pharmacodynamics of once-daily amikacin in various combinations with cefepime, aztreonam, and ceftazidime against Pseudomonas aeruginosa in an in vitro infection modelB J McGrath, E M Bailey, K C Lamp, et al.

Pharmacotherapy|April 30, 1999

Outcome assessment of minimizing vancomycin monitoring and dosing adjustmentsC M Karam, P S McKinnon, M M Neuhauser, et al.

Antimicrobial Agents and Chemotherapy|August 1, 1995

Pharmacodynamics of ceftazidime administered as continuous infusion or intermittent bolus alone and in combination with single daily-dose amikacin against Pseudomonas aeruginosa in an in vitro infection modelD M Cappelletty, S L Kang, S M Palmer, et al.

Antimicrobial Agents and Chemotherapy|January 1, 1996

Influence of antibiotic and E5 monoclonal immunoglobulin M interactions on endotoxin release from Escherichia coli and Pseudomonas aeruginosaK C Lamp, M J Rybak, B J McGrath, et al.

DICP : the Annals of Pharmacotherapy|July 1, 1991

Vancomycin protein binding in patients with infections caused by Staphylococcus aureusL M Albrecht, M J Rybak, L H Warbasse, et al.

Antimicrobial Agents and Chemotherapy|September 1, 1994

Bactericidal activities of teicoplanin, vancomycin, and gentamicin alone and in combination against Staphylococcus aureus in an in vitro pharmacodynamic model of endocarditisB J McGrath, S L Kang, G W Kaatz, et al.

Sexually Transmitted Diseases|April 1, 1989

Single dose enoxacin for the treatment of uncomplicated urogenital gonorrheaL M Albrecht, M J Rybak, H H Schubiner, et al.

Antimicrobial Agents and Chemotherapy|August 1, 1995

Bactericidal killing activities of cefepime, ceftazidime, cefotaxime, and ceftriaxone against Staphylococcus aureus and beta-lactamase-producing strains of Enterobacter aerogenes and Klebsiella pneumoniae in an in vitro infection modelS M Palmer, S L Kang, D M Cappelletty, et al.

Pageof 14

Showing results (81-90 of 131) with videos related to

Sort By:

Pageof 14

Clinical Pharmacokinetics|September 1, 1988

Inhibition of drug metabolism by quinolone antibioticsD J Edwards, S K Bowles, C K Svensson, et al.

Antimicrobial Agents and Chemotherapy|May 1, 1992

Pharmacokinetics and bactericidal rates of daptomycin and vancomycin in intravenous drug abusers being treated for gram-positive endocarditis and bacteremiaM J Rybak, E M Bailey, K C Lamp, et al.

Antimicrobial Agents and Chemotherapy|December 1, 1992

Pharmacodynamics of once-daily amikacin in various combinations with cefepime, aztreonam, and ceftazidime against Pseudomonas aeruginosa in an in vitro infection modelB J McGrath, E M Bailey, K C Lamp, et al.

Pharmacotherapy|April 30, 1999

Outcome assessment of minimizing vancomycin monitoring and dosing adjustmentsC M Karam, P S McKinnon, M M Neuhauser, et al.

Antimicrobial Agents and Chemotherapy|August 1, 1995

Pharmacodynamics of ceftazidime administered as continuous infusion or intermittent bolus alone and in combination with single daily-dose amikacin against Pseudomonas aeruginosa in an in vitro infection modelD M Cappelletty, S L Kang, S M Palmer, et al.

Antimicrobial Agents and Chemotherapy|January 1, 1996

Influence of antibiotic and E5 monoclonal immunoglobulin M interactions on endotoxin release from Escherichia coli and Pseudomonas aeruginosaK C Lamp, M J Rybak, B J McGrath, et al.

DICP : the Annals of Pharmacotherapy|July 1, 1991

Vancomycin protein binding in patients with infections caused by Staphylococcus aureusL M Albrecht, M J Rybak, L H Warbasse, et al.

Antimicrobial Agents and Chemotherapy|September 1, 1994

Bactericidal activities of teicoplanin, vancomycin, and gentamicin alone and in combination against Staphylococcus aureus in an in vitro pharmacodynamic model of endocarditisB J McGrath, S L Kang, G W Kaatz, et al.

Sexually Transmitted Diseases|April 1, 1989

Single dose enoxacin for the treatment of uncomplicated urogenital gonorrheaL M Albrecht, M J Rybak, H H Schubiner, et al.

Antimicrobial Agents and Chemotherapy|August 1, 1995

Bactericidal killing activities of cefepime, ceftazidime, cefotaxime, and ceftriaxone against Staphylococcus aureus and beta-lactamase-producing strains of Enterobacter aerogenes and Klebsiella pneumoniae in an in vitro infection modelS M Palmer, S L Kang, D M Cappelletty, et al.

Pageof 14